Latest news with #Mubadala


Zawya
19 hours ago
- Business
- Zawya
Sanad reports robust H1 2025 revenue of AED 3.2bln as global orderbook surpasses AED 38bln
H1 2025 Highlights Strong financial performance: Achieved AED 3.2 billion in H1 2025 revenue, up 39% year-on-year Global Momentum: 99% of revenue generated from international markets Record Orderbook: Orderbook reaches all-time high of AED 38 billion with AED 5 billion in new long-term agreements added in H1 2025 GTF MRO Leadership: Joins Pratt & Whitney GTF MRO network - first and only in the SAMENA region Strategic partnerships: Expanded collaborations with Etihad Airways, AMMROC, AerSale, AerCap, GE Aerospace, Lion Air, Garuda, and CFM International Infrastructure Investment: Investing over AED 150 million to expand MRO infrastructure and tooling Talent Growth: Workforce grew by 15% with 51 new hires; total headcount now 621; Emiratization at 34.6% Abu Dhabi, UAE: Sanad, the global aerospace engineering and leasing solutions leader wholly owned by Abu Dhabi's sovereign investor Mubadala Investment Company PJSC (Mubadala), today announced strong financial and operational results for the first half of 2025, reinforcing its role as a strategic enabler of the UAE's aviation and industrial ambitions. Sanad recorded revenues of AED 3.2 billion for H1 2025, marking a 39% increase over the same period last year, driven by continued momentum across its Maintenance, Repair, and Overhaul (MRO) and Asset Management divisions. Building on its AED 4.92 billion achieved in 2024, Sanad is on track to achieve projected full-year revenues of AED 5.4 billion in 2025. With 99% of H1 2025 revenues generated from international markets, Sanad is not only expanding its global footprint but also channeling international revenue streams into the UAE economy, reinforcing Abu Dhabi's position as a net exporter of advanced aerospace services and a rising force in the global aviation value chain. Expanding Global Orderbook and Strategic Agreements The Group's global orderbook has reached an all-time high of AED 38 billion, driven by long-term agreements with key partners and an expanding global footprint. Notable developments include Sanad's entry into the Pratt & Whitney GTF MRO Network as the first and only provider in the SAMENA region, as well as the expansion of MRO operations to Al Ain through its strategic partnership with AMMROC. New engine maintenance agreements were signed with leading global airliners such as Lion Air and Garuda Indonesia, while the Group strengthened its long-standing collaboration with CFM International to provide full overhaul services for LEAP-1A and LEAP-1B engines. The MRO division has successfully inducted 90 engines in the first half of 2025 and is on pace to complete 210 inductions by year-end, a 30% increase over 2024. This growth has been enabled by major infrastructure and tooling investments to expand capacity and meet rising global demand. Investing in Infrastructure, Tooling, and expanded Capabilities As part of its long-term strategy to position Abu Dhabi as a global hub for engine MRO, Sanad is investing over AED 150 million to expand and modernize its infrastructure, tooling, and facility capacity, laying the foundation for accelerated growth and enhanced service delivery worldwide: Upgraded engine test cell to enable full live testing of CFM LEAP engines, supporting both current and future customer requirements Commenced phased rollout of full LEAP engine MRO capabilities, positioning Sanad among a select group of global MRO providers equipped to service this high-demand platform Added new critical engine component repair capabilities for both LEAP and GEnx engines, marking a major milestone in expanding its advanced repair expertise and supporting faster turnaround times for airline customers. In parallel, Sanad expanded its Abu Dhabi headquarters by 3,600 sqm and commissioned a new 5,000 sqm MRO facility in Al Ain in partnership with AMMROC. These strategic investments significantly elevate Sanad's global competitiveness, technical capabilities and operational resilience, reinforcing its role as a catalyst for industrial innovation in the UAE and a trusted partner in the global aerospace value chain. Asset Management and Leasing Milestones Sanad continued to advance its position as a global asset management leader in H1 2025, executing high-impact transactions that are redefining aftermarket capabilities and strengthening its role in the global aviation supply chain. The Group acquired a portfolio of Rolls-Royce Trent 700 engines from Etihad Airways, significantly expanding its global asset management portfolio. In parallel, Sanad completed a strategic parts portfolio sale to AerSale, enhancing its aftermarket support capabilities. In one of the most notable transactions in the aviation leasing sector, Sanad also finalized a landmark AED 400 million engine and component sale with AerCap Materials, marking one of the largest asset sales of its kind to date. These strategic milestones reflect Sanad's agile, value-driven approach to asset management and underscore its growing influence in shaping the future of the global aviation aftermarket. Workforce Growth and Emirati Talent Development Sanad's success is driven by its people and the ability to attract, retain, and develop high-caliber talent in an increasingly competitive global aerospace market. Amid global talent shortages, the Group continued to grow and invest in future-ready capabilities: The workforce grew by 15% year on year, reaching 621 employees, including 51 new hires this year Emiratization rose to 34.6%, up from 28.3% in H1 2024 Delivered over 1384 training hours in H1 2025, focused on advanced MRO skills, safety, and leadership In H1, Sanad signed an MoU with GE Aerospace to drive immersive training and knowledge exchange. In parallel, two Emirati engineers began a six-month exchange program at Rolls-Royce facilities in the UK, part of a strategic initiative announced last year during the Farnborough Airshow. Sanad's structured programs like the Sanad Technical Development Programs, Future Leaders Program, and OEM-certified trainings, are designed to cultivate a world-class aerospace talent pipeline. Amer Siddiqui, Group Chairman of Sanad, stated:" Sanad's strong performance in the first half of 2025 reflects strategic clarity, disciplined execution, and the continued trust of our global partners. What sets Sanad apart is its unwavering commitment to building future-ready capabilities—investing in people, technology, and global collaborations. Through knowledge exchange and advanced technical development, Sanad is helping shape a resilient, knowledge-based aerospace ecosystem that embodies the UAE's bold industrial vision. It stands as a powerful example of how UAE-born champions can deliver sustainable growth, global relevance, and lasting impact." Mansoor Janahi, Managing Director and Group CEO of Sanad, said: Our performance in H1 2025 reflects the strength of our strategy, execution, and long-standing global partnerships. The expansion of our LEAP and GTF capabilities, the successful asset sale transactions, and our investments in infrastructure and talent all underscore Sanad's growing influence on the global aerospace stage. By embedding innovation into everything we do, whether through advanced MRO solutions or transformative talent development, we are not only meeting the evolving needs of our customers but also reinforcing Abu Dhabi's position as a global hub for aerospace excellence.' Looking ahead With a strong H1 foundation, Sanad is poised to deliver continued growth in H2 2025. The Group will advance global partnerships, scale infrastructure, and drive innovation to support rising demand for advanced MRO and asset management services. As Sanad continues to shape the future of aerospace, it remains committed to strengthening the UAE's industrial ecosystem and expanding its leadership across the global aviation value chain. About Sanad Sanad Group (Sanad) is a global aerospace engineering and leasing solutions leader headquartered in Abu Dhabi and wholly owned by Mubadala Investment Company PJSC. With over 37 years of operational experience, Sanad provides leaders in commercial aviation with world-class maintenance, repair, and overhaul (MRO) services and financing solutions. Visit us at Follow us on Instagram, Facebook, and LinkedIn @TheSanadGroup For more information, please contact: Hasna Abouseir habouseir@

Wall Street Journal
2 days ago
- Business
- Wall Street Journal
A Sovereign-Wealth Fund to Keep America's Technological Edge
If the U.S. wants to win the global race for technological supremacy, the country's best tool is a sovereign-wealth fund. Washington's haphazard approach to fueling national competitiveness and strategic industries isn't cutting it in today's environment. But intelligently deploying President Trump's proposed sovereign-wealth fund could secure American leadership in such critical technologies as quantum computing, artificial intelligence and advanced microchips. China is already shaping its technological future through strategic investment. The U.S. can't afford to cede leadership in technologies that will define the coming century. Other countries have used sovereign-wealth funds to great national advantage. Norway's Government Pension Fund Global is the premier example. It sets the standard for performance and transparency, delivering consistent returns while adhering to strict ethical guidelines. The Government of Singapore Investment Corp. generates outsize influence for the small nation. Oil-rich states leverage their wealth strategically with funds such as Abu Dhabi's Mubadala investment fund, which aims to position the United Arab Emirates as a global AI hub. Critics rightly point out that an American sovereign-wealth fund must be free of political interference and focused on commercial national research and defense priorities. But other nations' examples prove this is possible. There are also concerns about forming a fund when the U.S. is running budget deficits. The benefits far outweigh the risk. America needs this fund now more than ever. Both geopolitics and innovation shape the economy. It isn't enough to hope we maintain tech leadership through our financial dominance, banking leadership, private venture capital and intermittent government interventions. American firms have to grapple with difficult market distortions thanks to Chinese state investment, which places U.S. tech companies at a disadvantage. Beijing has formed various state-backed venture funds to invest in AI, quantum research and semiconductor manufacturing. These investments foster domestic innovation and advance strategic sectors. China's National Venture Capital Guidance Fund channels tens of billions of dollars of central, provincial and private capital into key technologies, aligning investments explicitly with industrial strategy.


Al Etihad
3 days ago
- Business
- Al Etihad
Mubadala announces additional investment in PCI Pharma Services
15 July 2025 17:28 A. SREENIVASA REDDY (ABU DHABI)Mubadala, the Abu Dhabi-based sovereign investor, has announced additional investment in PCI Pharma Services, a global leader in contract development and manufacturing (CDMO) for complex biologics and innovative investment is being made alongside private equity firms Bain Capital, Kohlberg, and existing investor Partners strategic transaction will see PCI enter its next phase of growth with support from this strong consortium of global investors. While financial terms were not disclosed, the partnership is expected to accelerate PCI's global expansion and bolster its capabilities in biopharma a post on X, Mubadala stated: 'This marks our continued support of PCI, following our initial commitment in 2020. Over the past five years, the company has demonstrated the strength of its global capabilities and its role in advancing innovation to improve patient access and outcomes.'Mina Hamoodi, Head of Healthcare at Mubadala, commented: 'Our reinvestment in PCI reflects our deep conviction in the company's mission, leadership, and long-term potential. At this important juncture, we are delighted to welcome Bain Capital, an industry-leading healthcare investor with deep expertise in growing pharma services businesses, as a partner.'She added: 'We look forward to partnering with Bain and Kohlberg, and working closely with PCI's outstanding management team, as the company enters its next chapter of accelerated growth.'Partners Group will also continue to support PCI with a minority investment. Sujit John, Managing Director, Private Equity Health & Life at Partners Group, said: "PCI's market position, reputation, and world-class capabilities strategically position the Company to be the partner of choice for customers. We look forward to supporting PCI and the new ownership group in driving the Company into its next phase of growth.'Headquartered in Philadelphia, PCI has over 7,500 employees across 38 sites in seven countries. The company offers integrated services across the entire drug development lifecycle, and its continued investments in sterile injectables and high-potency manufacturing will strengthen pharmaceutical supply chains in the US and beyond. Source: Aletihad - Abu Dhabi


Arabian Business
3 days ago
- Business
- Arabian Business
Mubadala becomes part of new consortium to acquire Techem for $7.9bn
Mubadala Investment Company, Abu Dhabi's sovereign wealth fund, is acquiring Germany's Techem, an international provider of digitally enabled solutions for the real estate sector, for a total consideration of AED 29 billion (US$7.9 billion). Partners Group, one of the largest firms in the global private markets industry; GIC, a leading global investor; and TPG Rise Climate, the dedicated climate investing strategy of TPG's global impact investing platform, are the other involved companies. The transaction is expected to close in the second half of 2025, subject to customary conditions and regulatory approvals. Founded in 1952, Techem serves over 440,000 customers across 18 countries and manages more than 13 million dwellings. About 62 million of its devices are installed worldwide, helping the property industry and private landlords improve energy efficiency, cut consumption, costs, and CO 2 emissions through low-cost, non-invasive methods. Techem's services contribute to the long-term decarbonisation of the real estate sector, which accounts for around 40 per cent of global CO 2 emissions. In 2018, Techem was acquired by a consortium led by Partners Group's Private Equity business, alongside co-investors La Caisse and Ontario Teachers' Pension Plan. The group oversaw a period of strong growth at the company, with revenues reaching over EUR1 billion (US$1.17 billion) and EBITDA growing around 50 per cent. As part of the new transaction, the earlier consortium will exit their stakes in Techem and the new ownership consortium will implement a value creation plan focused on strengthening its position as a leading digital-first provider of submetering solutions for the real estate sector across Europe. This will be done by further digitalising operations, adding complementary offerings such as smart meters, and enabling other digital services focused on improving building efficiency. Abdulla Mohamed Shadid, Head of Energy and Sustainability at Mubadala's Private Equity Platform, commented: 'The decarbonisation of the real estate sector continues to be a global priority for better and more sustainable living. As a trusted and leading sub-metering services provider with a digital edge, Techem is well-positioned to continue leading this transition, improving the energy management of buildings through better efficiency and consumption. 'We are delighted to be investing alongside Partners Group, GIC, and TPG Rise Climate and to be supporting Techem as it continues to expand and strengthen its value proposition. This transaction aligns with Mubadala's long-term commitment to deploying capital purposefully and helping to find solutions to global challenges.' Following the acquisition, Partners Group's infrastructure business will have a controlling stake in Techem on behalf of its clients. David Daum, Partner, Head Infrastructure Europe, Partners Group, added: 'Over the past seven years, together with La Caisse and Ontario Teachers', our private equity business built Techem into a global energy services provider. We see great potential for the company moving forward and are pleased to be able to continue to actively drive this success story with our new investors GIC, TPG Rise Climate, and Mubadala. Energy efficiency is a key thematic focus, and Techem is poised to continue benefiting from the thematic tailwinds of the push for decarbonisation.'


Arabian Business
3 days ago
- Business
- Arabian Business
Mubadala makes significant reinvestment in PCI Pharma Services
Mubadala Investment Company, the Abu Dhabi-based sovereign wealth fund managing a global portfolio, is making a significant reinvestment in PCI Pharma Services (PCI). Headquartered in Philadelphia, Pennsylvania, PCI provides clients with integrated end-to-end drug development, manufacturing and packaging capabilities that increase their products' speed to market and opportunities for commercial success. PCI has over 450 successful product launches over the last five years and has over 50 years of experience in pharmaceutical services, helping bring to life innovation to improve patient access and outcomes. Mubadala reinvests in pharma giant The strategic investment also included Bain Capital as a new investor, as well as existing lead investor Kohlberg, who hold majority stakes in PCI along with Mubadala. Partners Group will also continue to support PCI with a minority investment. This investment marks Mubadala's continued support of PCI, following its initial investment alongside Kohlberg in 2020. Financial details of the private transaction were not disclosed, but the deal values PCI at US$10 billion, including debt, according to a Wall Street Journal report. Camilla Languille, co-CEO of Private Equity at Mubadala, commented: 'PCI Pharma Services has been one of our top-performing healthcare investments and is a testament to what can be achieved when long-term active investors partner with strong management teams to catalyse growth, create value, and deliver better patient outcomes worldwide. 'Our team will continue to focus on similar opportunities in the healthcare space as the sustained outsourcing of mission-critical but non-core activities by pharma companies aligns with our commitment to address global unmet clinical needs, reduce the cost of care to the system, and enable greater access.' The new capital will enable PCI to focus on both organic and inorganic growth initiatives, including expanding its suite of services and geographic reach. Leveraging global growth trends in biologics and specialised drug therapies, PCI's future investments will include expansion of existing sterile fill-finish of injectables and high potent and specialised manufacturing capacity. The strategic investment will also enable PCI's significant continued investment in the US, bolstering the nation's critical pharmaceutical manufacturing and supply chain infrastructure. Mina Hamoodi, Head of Healthcare at Mubadala, added: 'Our reinvestment in PCI reflects our deep conviction in the company's mission, leadership, and long-term potential. 'At this important juncture, we are delighted to welcome Bain Capital, an industry-leading healthcare investor with deep expertise in growing pharma services businesses, as a partner. We look forward to partnering with Bain and Kohlberg, and working closely with PCI's outstanding management team, as the company enters its next chapter of accelerated growth.' Salim Haffar, Chief Executive Officer, PCI, said: 'PCI has embarked on a purposeful journey to transform itself into a global CDMO by executing its successful growth strategy, providing industry-leading customer experience, and offering innovative and integrated supply chain solutions. 'I am grateful for the ongoing support of our existing investors and enthusiastically welcome Bain Capital and their deep, global healthcare and life science capabilities and expertise. Together we will grow PCI's commercial, clinical trial services, and development and manufacturing businesses to meet the future demands of our biopharmaceutical customers.'